Graft-versus-myeloma effect in two cases

Lancet

Volumn 347, Issue 9004, 1996, Pages 800-801

  Verdonck, Leo F ^a   Lokhorst, Henk M ^a   Dekker, Adriaan W ^a   Nieuwenhuis, H Karel ^a   Petersen, Eefke J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKAPHERESIS; LEUKOCYTE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0029927579     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90871-5     Document Type: Article

References (10)

1. Weiden PL, Flourney N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-73.
2. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-62.
3. Marmost AM , Horowitz MM, Gale RP, et al. T-cell Depletion of HLA-identical transplants in leukemia. Blood 1989; 78: 2120-30.
4. Verdonck LF, Dekker AW, De Gast GC, Van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Allogeneic bone marrow transplantation with a fixed low number of cells in the marrow graft. Blood 1994; 83: 3090-66.
5. Kolb HJ, Mittermüller J, Clemm Ch, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-65.
6. Bortin MM, Truitt RL, Rimm AA, Bach FH. Graft-versus-leukemia reactivity induced by alloimmunization without augmentation of graft-versus-host reactivity. Nature 1979; 281: 490-92.
7. Verdonck LF, Van Heugten HG, Giltay J, Franks CR. Amplification of the graft-versus-leukemia effect in man by interleukin-2. Transplantation 1991; 51: 1120-24.
8. Sullivan KM, Storb R, Buckner CD, et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med 1989; 320: 828-34.
9. Drobyski WR, Keever CA, Roth MS, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-18.
10. Porter DL, Roth MS, McGarigle C, Ferrar JLM, Antin JH. Induction of graft-versus-host disease as immunotherapy for erelapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100-06.